Abstract:Purpose: Though many previous studies of gray matter volume provided evidences to support the anatomical deficits mainly involving the cortical thalamo-cortical circuits, the results were quite inconsistent. Furthermore, the gray matter volume of a cortical region represents the combination of cortical thickness and surface area, features which are believed to be influenced by different genetic factors related to sulcal patterning and the thickness of the cortical mantle itself. Cortical thickness reflects the size, density and arrangement of neurons, neuroglia and nerve fibers, and thus its measurement could provide important and relatively unique information about disease-specific neuroanatomical changes. However, few studies had explored the deficits of cortical thickness in schizophrenia. Thus the aim of current study was to explore the difference of cortical thickness between 128drug-naïve, first-episode schizophrenia patients and 141 healthy controls. Methods: This study was approved by the local ethical committee and written informed consent was obtained from all subjects. 128 antipsychotic-naïve, first-episode schizophrenia patients and 141 healthy comparison subjects were recruited in the present research. Both patients and healthy controls were performed MR examination via a 3-Telsa GE MRI system with an 8 channel phase array head coil. We employed CIVET software (version 1.1.9, Montreal Neurological Institute at McGill University, Montreal, Quebec, Canada) to extract cortical thickness measurements from T1-weighted MRI images. Vertex-based 2-sample t-test was applied to investigate cortical thickness differences between the patient group and the healthy control group with age and sex as covariance. Statistical significance was set at p<0.05 with false discovery rate correction for multiple comparisons. Global Assessment of Functioning Scale (GAF) and Positive and Negative Syndrome Scale (PANSS) were used to assess the neuropsychological functioning and clinical symptoms of schizophrenia patients. Besides, correlation analysis between significant difference of cortical thickness in patient group and scale scores was performed to reveal the potential association between the anatomical deficits and clinical symptoms. Results: Compared to the control group, schizophrenia patients showed significantly cortical thinning in the bilateral dorsolateral prefrontal cortices (DLPFC), left precentral gyrus, left orbitofrontal cortex (OFC), right precentral and postcentral gyri and thickening in bilateral temporal poles, left medial orbitofrontal cortex (med-OFC), left cuneus and right insula (P <0.05)(Figure 1). Meanwhile, the cortical thickness of right DLPFC, bilateral temporal poles, bilateral precentral gyri and left OFC were negatively correlated with the severities of symptoms in patients as identified by PANSS scores for positive symptoms, thought disturbance, activation or depression (Table 1). While positive correlations were found between the cortical thickness of left temporal pole, left cuneus and GAF scores, and between that of right precentral gyrus, left DLPFC and PANSS scores for general psychopathology symptoms as well as depression. Discussion: The current studies in the largest sample of drug-naïve, first-episode schizophrenia exhibited significant changes including both thinning and thickening performances of cortical thickness in many cerebral cortices. These obvious alterations of cortices at the very beginning of disease may in some degree facilitate to partly explain the complex neuropathological mechanism of schizophrenia. The cortical thinning, especially, the right DLPFC, may be resulted from neuroprogression characterized by reduced number of neurons or malformation of cortices in schizophrenia. Interestingly, cortical thickening in bilateral temporal poles and other cortices were also revealed and may result from the compensatory mechanism or abnormal neurodevelopment at early stage of schizophrenia. In addition, a strong link between symptoms and cortical thickness displayed a consensus between cerebral structure and clinical manifestations. Conclusion: The significant alteration of cortical thickness at the very beginning of antipsychotic-naïve, first-episode patients of schizophrenia provided evidences to support the aberrations in the neurodevelopmental process in schizophrenia. In the further study, longitudinal research about the structural characteristics together with function and clinical symptoms should be performed to investigate the trajectory of disease.

Brain Volume Reductions in Medication-Naive Patients with Schizophrenia in Relation to Intelligence Quotient

Decreased Left Middle Temporal Gyrus Volume in Antipsychotic Drug-Naive, First-Episode Schizophrenia Patients and Their Healthy Unaffected Siblings

Brain Volumes in Schizophrenia: a Meta-Analysis in over 18 000 Subjects.

Association of IQ Changes and Progressive Brain Changes in Patients with Schizophrenia

Brain Volume Changes in First-Episode Schizophrenia

Gray matter volume alterations in first-episode drug-naïve patients with deficit and nondeficit schizophrenia

Brain Morphology in Antipsychotic-Naïve Schizophrenia: a Study of Multiple Brain Structures.

Confounders of Excessive Brain Volume Loss in Schizophrenia

Relationship Between Body Mass Index and Volume Ratio of Brain Gray Matter in Patients with First-episode Schizophrenia

Volume Changes in Gray Matter in Patients with Schizophrenia.

Brain Volumes As Predictor of Outcome in Recent-Onset Schizophrenia: A Multi-Center Mri Study

Hippocampal and Orbital Inferior Frontal Gray Matter Volume Abnormalities and Cognitive Deficit in Treatment-Naive, First-Episode Patients with Schizophrenia.

Progressive Brain Volume Loss in Schizophrenia over the Course of the Illness: Evidence of Maturational Abnormalities in Early Adulthood

An Optimized Voxel-Based Morphometry MRI Study of the Brain in Patients with First Episode Schizophrenia

Decrease in Temporal Gyrus Gray Matter Volume in First-Episode, Early Onset Schizophrenia: an MRI Study.

Brain Volume Changes after Withdrawal of Atypical Antipsychotics in Patients with First-Episode Schizophrenia

Prognostic Utility of Multivariate Morphometry in Schizophrenia.

O6.3. PATTERNS OF GRAY MATTER ABNORMALITIES IN PATIENTS WITH FIRST-EPISODE AND TREATMENT-NAïVE SCHIZOPHRENIA

Cortical Thickness Revealing Cerebral Anatomical Deficits in Drug-naive First-episode Schizophrenia

Subcortical Brain Volume Abnormalities in 2028 Individuals with Schizophrenia and 2540 Healthy Controls Via the ENIGMA Consortium